19/12/2022
We're delighted to have assisted Shield Therapeutics plc with shareholder documentation for its incredibly successful - upsized twice and still oversubscribed! - US$18.5m fundraising by means of a placing and open offer of up to £3.9m. Congratulations to the company and its advisors Taylor Wessing and finnCap Group on this great achievement!
Other recent news
